Heart Failure

The study found that avoiding 3 key risk factors-diabetes, obesity, and hypertension-by age 45, greatly increased the likelihood of avoiding heart failure through the end of life.

A study inspired by a patient who could not afford his heart medication shows that there was no pattern to price variability for a common regimen to treat heart failure, which could contribute to poor adherence.

A study of a pair of large databases shows a strong link between obesity and heart failure.

Patients who suffer heart attacks or flare-ups of congestive heart failure can fare worse in hospitals that are more likely to send them to the intensive care unit (ICU), according to a study published in CHEST.

Two studies presented at Heart Failure 2016 and the 3rd World Congress on Acute Heart Failure held in Florence, Italy, hold good news for patients with heart failure who get flu shots.

A secondary analysis of data from the TECOS trial of sitagliptin finds that the drug does not affect the risk for heart failure hospitalization or related adverse clinical outcomes in people with type 2 diabetes

A new trial from the National Institutes of Health found that a lower systolic blood pressure goal of 120 mm Hg reduces risk of cardiovascular events in geriatric populations.

One year after being hospitalized for heart failure, one-third of patients had not returned to work, according to a study presented at Heart Failure 2016 and the 3rd World Congress on Acute Heart Failure.

US and European professional societies coordinated their announcement to reduce confusion for physicians and payers.

Cancer patients who receive a particular type of chemotherapy, called doxorubicin, run a risk of sustaining severe, lasting heart damage. But until now, there was no way of knowing who would experience this serious side effect.

While health plans and PBMs have taken a variety of approaches to control spending on the new class of cholesterol fighting drugs, Cigna is the first to reach value-based agreements with the drug makers.

Discovery of a previously unknown heart muscle protein and how it affects mechanisms related to heart failure may lead to further treatments for cardiovascular disease.

Despite a high prevalence, rates of cardiac dysfunction and diastolic dysfunction are overwhelmingly unrecognized among the Latino/Hispanic population in the United States.

A new study finds that more than one-third of heart failure (HF) patients do not receive recommended HF-specific medications within 30 days of diagnosis.

A diabetes drug may have benefits for people with chronic heart failure. Boehringer Ingelheim and Eli Lilly and Company have announced plans to investigate the use of the diabetes medicine Jardiance for heart failure with 2 outcome trials.

Fewer than 3% of Americans are active enough, eat a healthy diet, are nonsmokers, and have a healthy weight and percentage of body fat-the 4 important elements of a heart-healthy lifestyle that are promoted by the American Heart Association.

Data on drug prescriptions, diagnoses, and events are increasingly being used for epidemiologic and pharmacologic studies and for the evaluation of quality of care, but questions arise about how complete and accurate the diagnoses and events in these databases are.

Study finds a first heart attack is more likely to lead to heart failure in patients when the burden of coronary artery disease increases.

A new study in behavioral cardiology establishes a strong link between posttraumatic stress disorder and an increased risk for cardiovascular diseases and deaths.

Intracoronary gene transfer among heart failure patients increased left ventricular function beyond standard heart failure therapy.

Heart failure patients who have early follow-up with general medicine or cardiology providers within 7 days of discharge from the hospital had 19% had lower odds of readmission within 30 days.

The study from researchers at Cleveland Clinic found that during the years before full implementation of the Affordable Care Act, a shift in treatment methods for patients with a painful condition was associated with fewer amputations and deaths. But large disparities remain.

Light-to-moderate alcohol consumption might actually be a good thing for the heart and heart diseases, according to the recent results of a study out of Norway.

In a nationwide cross-sectional comparison of organizational structure for chronic disease management, less attention was given to chronic obstructive pulmonary disease than chronic heart failure.